Novartis' Entresto flops crucial heart failure trial, imperiling $5B sales goal
admin 29th July 2019 Uncategorised 0Entresto’s blockbuster turn in 2018 was a long time coming for Novartis, which held on to a $5 billion vision for the drug even as its launch lagged. Those dreams took another hit Monday when Entresto flopped a phase 3 trial.
More: Novartis' Entresto flops crucial heart failure trial, imperiling B sales goal
Source: fierce